1. Home
  2. TMDX vs MGNI Comparison

TMDX vs MGNI Comparison

Compare TMDX & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$83.30

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Magnite Inc.

MGNI

Magnite Inc.

HOLD

Current Price

$23.39

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
MGNI
Founded
1998
2007
Country
United States
United States
Employees
N/A
514
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
TMDX
MGNI
Price
$83.30
$23.39
Analyst Decision
Buy
Strong Buy
Analyst Count
9
9
Target Price
$148.22
$25.22
AVG Volume (30 Days)
847.3K
2.8M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
382.18
493.75
EPS
0.61
0.16
Revenue
$605,494,000.00
$156,414,000.00
Revenue This Year
$24.25
$6.28
Revenue Next Year
$18.75
$9.76
P/E Ratio
$144.97
$148.13
Revenue Growth
37.13
25.45
52 Week Low
$60.11
$10.82
52 Week High
$156.00
$26.19

Technical Indicators

Market Signals
Indicator
TMDX
MGNI
Relative Strength Index (RSI) 45.40 57.09
Support Level $66.64 $17.50
Resistance Level $95.18 $25.41
Average True Range (ATR) 3.49 0.75
MACD -0.96 -0.24
Stochastic Oscillator 4.56 14.41

Price Performance

Historical Comparison
TMDX
MGNI

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About MGNI Magnite Inc.

Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.

Share on Social Networks: